Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEMO: Neuropsychological Effects of Nitrous Oxide
NCT06557642Recruiting
- Sponsor
- University of Oxford
- Start
- Jul 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nitrous oxide in major depressive disorder (MDD) (2 arms), sponsored by University of Oxford. Primary endpoint: Changes in Emotional Ratings of Personal Memories (Memory Reconsolidation). Started Jul 2024; status: recruiting.
02
Drugs
nitrous oxide
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06557642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06557642.